City of Hope Reveals Vision for World-Class Cancer Care in Orange County

June 25, 2019 | City of Hope

City of Hope has accelerated its plans for a $1 billion comprehensive cancer campus in Orange County, bringing highly specialized cancer care, clinical trials, precision medicine and early detection to the nation’s sixth most populous county.

Continue Reading

Blood test could predict breast cancer relapse

July 8, 2019 | Zen Vuong

A special blood test may one day predict if a newly diagnosed breast cancer patient will likely relapse years later, a City of Hope study suggests.

Researchers detail new findings at 2019 AACR meeting

March 28, 2019 | Zen Vuong

City of Hope will showcase ongoing studies and data on chimeric antigen receptor (CAR) T cell therapy, immunotherapy against solid tumors and more at the American Association for Cancer Research annual meeting from March 29 through April 3 in Atlanta.

Meet Kim Margolin, M.D.: Leading the fight against melanoma - and winning

May 28, 2018 | Maxine Nunes

When Kim Margolin, M.D., talks about her work, the words are packed with information and pour out with energy and passion. It’s easy to see what makes her an internationally recognized leader in the fight against melanoma.

Peter P. Lee, M.D.: Chasing Cancer from All Angles

February 8, 2017 | Abe Rosenberg

In Peter Lee's latest project, he directs a diverse, far-flung team that's examining breast tumors' so-called “microenvironment,” or the non-cancerous cells that surround and support the tumor, and how they affect the immune system.

Peter P. Lee, M.D. On His Multidisciplinary Approach to Cancer Research

February 8, 2017 | Abe Rosenberg

Peter Lee is leading a multidisciplinary team seeking to learn how breast tumors and their microenvironment affect the immune system.

Advances: New Immunotherapy Treatments for Breast Cancer in 2017

December 23, 2016 | Katie Neith

Peter P. Lee, M.D., a City of Hope oncologist, has for 20 years been interested in treating cancer by stimulating or enhancing a person’s own immune system. This approach, called immunotherapy, has gained much attention in recent years. Lee's outlook for 2017 is full of promise for a more personalized approach to the disease.